EGFR and non-small cell lung carcinoma: Furthermore, WBRT and EGFR-TKI (gefitinib) are shown to have therapeutic effects on brain metastasis of NSCLC, and DCE-MRI and DWI can be used to evaluate the efficacy of this combined treatment.